| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 16.647 | 23.639 | 10.315 | 16.982 | 58.603 | 56.280 | 123.038 | 169.314 |
| Total Income - EUR | - | - | 16.647 | 23.639 | 10.315 | 17.393 | 58.603 | 56.280 | 123.038 | 169.314 |
| Total Expenses - EUR | - | - | 6.252 | 9.787 | 16.760 | 6.156 | 16.234 | 34.278 | 57.595 | 69.554 |
| Gross Profit/Loss - EUR | - | - | 10.394 | 13.851 | -6.445 | 11.237 | 42.369 | 22.002 | 65.443 | 99.760 |
| Net Profit/Loss - EUR | - | - | 10.052 | 13.614 | -6.548 | 10.728 | 41.181 | 20.669 | 64.237 | 94.782 |
| Employees | - | - | 1 | 1 | 1 | 2 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Sanogyn Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 41.644 | 82.503 | 61.851 | 41.217 |
| Current Assets | - | - | 10.937 | 23.751 | 5.965 | 7.575 | 16.930 | 6.275 | 47.491 | 134.334 |
| Inventories | - | - | 46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 986 | 15.081 | 0 | 1.421 | 2.482 | 1.685 | 9.755 | 69.226 |
| Cash | - | - | 9.904 | 8.670 | 5.965 | 6.154 | 14.448 | 4.590 | 37.736 | 65.108 |
| Shareholders Funds | - | - | 10.095 | 43 | -6.506 | 41 | 36.832 | 20.710 | 64.278 | 94.823 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 841 | 23.708 | 12.471 | 7.534 | 21.742 | 68.068 | 45.064 | 80.729 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sanogyn Medical Srl